Emtricitabine Supplier-Buyer Network — Trade Flow Analysis

Name: Emtricitabine Supplier-Buyer Trade Network Dataset — 141+ Indian Exporters, 22+ Importers, 117+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Emtricitabine supplier network, Emtricitabine buyers, pharmaceutical export India, Emtricitabine trade data

TransData Nexus

Emtricitabine

India Pharmaceutical Trade Intelligence

$119.4M141 Suppliers117 CountriesHS 30049099

ExportsIndia → SOUTH AFRICA26.2%India → UNITED STATES13.1%

ImportsUNITED STATES → India$942.1K CANADA → India$171.0K

#1 Supplier: MYLAN LABORATORIES

Who Supplies Emtricitabine? Top Manufacturers & Buyers 2026 — MYLAN LABORATORIES LIMITED Leads | TransData Nexus | TransData Nexus

1MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the first-largest Emtricitabine exporter from India, with a market share of 22.8% and a total export value of $27.2M across 265 shipments. Their average shipment value of $102.6K is above the market average of $54.4K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. VIATRIS HEALTHCARE (PTY) LTD, is the dominant customer, accounting for 51.5% of this supplier's tracked business. Top customers include:

• VIATRIS HEALTHCARE (PTY) LTD, — $14.0M across 136 shipments (51.5% of this supplier's total exports)

• NATIONAL AIDS COUNCIL (NAC), — $9.9M across 96 shipments (36.3% of this supplier's total exports)

• EMBASSY OF THE UNITED STATES OF AME — $1.2M across 12 shipments (4.6% of this supplier's total exports)

• MINISTERIO DE SALUD — $1.1M across 10 shipments (3.9% of this supplier's total exports)

• SAI PHARMA CO LTD — $997.3K across 10 shipments (3.7% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $102.6K is 89% above the market average of $54.4K, consistent with large-order contracts or value-added formulations.

2MACLEODS PHARMACEUTICALS LTD

MACLEODS PHARMACEUTICALS LTD is the second-largest Emtricitabine exporter from India, with a market share of 22.2% and a total export value of $26.5M across 280 shipments. Their average shipment value of $94.5K is above the market average of $54.4K, suggesting premium or bulk contract pricing.

MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• MACLEODS PHARMACEUTICALS SA — $11.3M across 119 shipments (42.5% of this supplier's total exports)

• ZYDUS FRANCE — $8.1M across 86 shipments (30.7% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS EUROPE LTD — $3.6M across 38 shipments (13.6% of this supplier's total exports)

• ICU VITA — $2.0M across 22 shipments (7.7% of this supplier's total exports)

• SYNOPTIS INDUSTRIAL SP .ZO.O — $1.4M across 15 shipments (5.5% of this supplier's total exports)

Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $94.5K is 74% above the market average of $54.4K, consistent with large-order contracts or value-added formulations.

3AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the third-largest Emtricitabine exporter from India, with a market share of 3.5% and a total export value of $4.2M across 118 shipments. Their average shipment value of $35.7K is below the market average of $54.4K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• APL SWIFT SERVICES (MALTA) LTD., — $1.7M across 48 shipments (41.0% of this supplier's total exports)

• AUROLOGISTICS LLC (AUROBINDO PHARMA — $1.3M across 36 shipments (30.8% of this supplier's total exports)

• AUROBINDO PHARMA USA — $568.9K across 16 shipments (13.5% of this supplier's total exports)

• QUALLENT PHARMACEUTI — $316.9K across 9 shipments (7.5% of this supplier's total exports)

• AUROBINDO PHARMA USA — $300.9K across 8 shipments (7.2% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (118 shipments) at a per-shipment value of $35.7K, indicating a broad distribution network with many smaller, regular orders.

4LUPIN LIMITED

LUPIN LIMITED is the fourth-largest Emtricitabine exporter from India, with a market share of 3.0% and a total export value of $3.6M across 43 shipments. Their average shipment value of $82.9K is above the market average of $54.4K, suggesting premium or bulk contract pricing.

LUPIN LIMITED serves 5 named buyers in our database. LUPIN HEALTHCARE (UK) LIMITED is the dominant customer, accounting for 61.7% of this supplier's tracked business. Top customers include:

• LUPIN HEALTHCARE (UK) LIMITED — $2.2M across 27 shipments (61.7% of this supplier's total exports)

• LUPIN HEALTHCARE (UK) LIMITED — $675.6K across 8 shipments (19.0% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS EUROPE LTD — $254.8K across 3 shipments (7.2% of this supplier's total exports)

• TRANS-O-FLEX LOGISTI — $237.4K across 3 shipments (6.7% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS EUROPE LTD — $196.6K across 2 shipments (5.5% of this supplier's total exports)

Key Insight: LUPIN LIMITED's per-shipment value of $82.9K is 52% above the market average of $54.4K, consistent with large-order contracts or value-added formulations.

5HETERO LABS LIMITED

HETERO LABS LIMITED is the fifth-largest Emtricitabine exporter from India, with a market share of 2.9% and a total export value of $3.4M across 67 shipments. Their average shipment value of $50.9K is below the market average of $54.4K, reflecting a high-volume, competitive pricing strategy.

HETERO LABS LIMITED serves 5 named buyers in our database. TO THE ORDER OF is the dominant customer, accounting for 54.0% of this supplier's tracked business. Top customers include:

• TO THE ORDER OF — $1.8M across 36 shipments (54.0% of this supplier's total exports)

• NA — $967.7K across 19 shipments (28.4% of this supplier's total exports)

• XXN AXXRICXX HEXXTH — $203.7K across 4 shipments (6.0% of this supplier's total exports)

• XXN AXXRICXX HEXXTH — $203.5K across 4 shipments (6.0% of this supplier's total exports)

• M S TO THE ORDER OF — $194.5K across 4 shipments (5.7% of this supplier's total exports)

Key Insight: HETERO LABS LIMITED operates with high shipment frequency (67 shipments) at a per-shipment value of $50.9K, indicating a broad distribution network with many smaller, regular orders.

6CIPLA LIMITED

CIPLA LIMITED is the fifth-largest Emtricitabine exporter from India, with a market share of 2.2% and a total export value of $2.6M across 40 shipments. Their average shipment value of $65.1K is above the market average of $54.4K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $964.0K across 15 shipments (37.0% of this supplier's total exports)

• CIPLA AUSTRALIA PTY — $597.7K across 9 shipments (22.9% of this supplier's total exports)

• APOTEX AUSTRALIA — $480.0K across 7 shipments (18.4% of this supplier's total exports)

• MEGALABS CHILE S A — $317.7K across 5 shipments (12.2% of this supplier's total exports)

• CIPLA COLOMBIA SAS Y — $246.0K across 4 shipments (9.4% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $65.1K is 20% above the market average of $54.4K, consistent with large-order contracts or value-added formulations.

1South Africa

South Africa ranks as the first-largest destination for Emtricitabine imports from India, with a total trade value of $31.3M across 30 shipments — representing a 26.2% share of all Emtricitabine exports. The average shipment value of $1.0M is above the global average of $54.4K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Emtricitabine importers in South Africa: VIATRIS HEALTHCARE (PTY) LTD, is the largest buyer, accounting for 46.2% ($14.5M) of this market's total imports.

• VIATRIS HEALTHCARE (PTY) LTD, — $14.5M (46.2% of South Africa's total)

• MACLEODS PHARMACEUTICALS SA — $12.0M (38.5% of South Africa's total)

Key Insight: South Africa's per-shipment average of $1.0M (1815% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

South Africa is a key market for Emtricitabine imports from India.

Primary Market

Secondary Market

2United States

United States ranks as the second-largest destination for Emtricitabine imports from India, with a total trade value of $15.6M across 101 shipments — representing a 13.1% share of all Emtricitabine exports. The average shipment value of $154.8K is above the global average of $54.4K, indicating high-value procurement contracts or branded formulations. This market is served by 6 tracked buyers.

Named Emtricitabine importers in United States: AUROLOGISTICS LLC (AUROBINDO PHARMA is the largest buyer, accounting for 14.0% ($2.2M) of this market's total imports.

• AUROLOGISTICS LLC (AUROBINDO PHARMA — $2.2M (14.0% of United States's total)

• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $1.9M (12.0% of United States's total)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $1.7M (10.8% of United States's total)

Key Insight: United States's per-shipment average of $154.8K (185% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Emtricitabine imports from India.

Primary Market

Secondary Market

3Zimbabwe

Zimbabwe ranks as the third-largest destination for Emtricitabine imports from India, with a total trade value of $10.4M across 2 shipments — representing a 8.7% share of all Emtricitabine exports. The average shipment value of $5.2M is above the global average of $54.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Emtricitabine importers in Zimbabwe: NATIONAL AIDS COUNCIL (NAC), is the largest buyer, accounting for 94.8% ($9.9M) of this market's total imports.

• NATIONAL AIDS COUNCIL (NAC), — $9.9M (94.8% of Zimbabwe's total)

Key Insight: Zimbabwe's per-shipment average of $5.2M (9484% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Zimbabwe is a key market for Emtricitabine imports from India.

Primary Market

Secondary Market

4United Kingdom

United Kingdom ranks as the fourth-largest destination for Emtricitabine imports from India, with a total trade value of $9.8M across 21 shipments — representing a 8.2% share of all Emtricitabine exports. The average shipment value of $468.4K is above the global average of $54.4K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Emtricitabine importers in United Kingdom: LUPIN HEALTHCARE (UK) LIMITED is the largest buyer, accounting for 43.9% ($4.3M) of this market's total imports.

• LUPIN HEALTHCARE (UK) LIMITED — $4.3M (43.9% of United Kingdom's total)

• GLENMARK PHARMACEUTICALS EUROPE LTD — $3.6M (36.7% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $468.4K (761% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Emtricitabine imports from India.

Primary Market

Secondary Market

5France

France ranks as the fifth-largest destination for Emtricitabine imports from India, with a total trade value of $8.9M across 12 shipments — representing a 7.4% share of all Emtricitabine exports. The average shipment value of $738.2K is above the global average of $54.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Emtricitabine importers in France: ZYDUS FRANCE is the largest buyer, accounting for 92.6% ($8.2M) of this market's total imports.

• ZYDUS FRANCE — $8.2M (92.6% of France's total)

Key Insight: France's per-shipment average of $738.2K (1256% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Emtricitabine imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Emtricitabine.
2.Flow Mapping: 141 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,194 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 117 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,194 Verified Shipments

141 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Emtricitabine

Emtricitabine

Who Supplies Emtricitabine? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Emtricitabine? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Emtricitabine Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MYLAN LABORATORIES LIMITED

2MACLEODS PHARMACEUTICALS LTD

3AUROBINDO PHARMA LTD

4LUPIN LIMITED

5HETERO LABS LIMITED

6CIPLA LIMITED

From Indian Factories to Global Pharmacies — How Emtricitabine Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Emtricitabine Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1South Africa

2United States

3Zimbabwe

4United Kingdom

5France

People Also Ask — Emtricitabine Supplier & Trade Network

Emtricitabine Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology